Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of SynFlow Duro System in the Treatment of Post Cardiotomy Cardiogenic Shock: a Prospective, Multicenter, Single-arm Clinical Trial

NCT07560085 is registered in ClinicalTrials.gov with ForQaly Medical (Shanghai) Co., Ltd as lead sponsor.

NCT NCT07560085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07560085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of SynFlow Duro System in the Treatment of Post Cardiotomy Cardiogenic Shock: a Prospective, Multicenter, Single-arm Clinical Trial
Lead sponsor
ForQaly Medical (Shanghai) Co., Ltd
Phase
Not applicable
Overall status
Recruiting
Start date
July 14, 2026
Completion date
June 30, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock